Imaging of Corneal and Crystalline by Near Infrared Retro-illumination
NCT ID: NCT05717543
Last Updated: 2023-04-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
384 participants
INTERVENTIONAL
2023-01-26
2023-03-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
oCular Examination at Cell RESolution With Optical TransmissionTomography
NCT06976034
A Pilot Study to Test the Safety and Feasibility of a Brillouin Ocular Analyzer
NCT01775007
A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging
NCT00556114
Retinal Oximtery Following Treatment for Diabetic Maculopathy
NCT01549132
Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases
NCT01546181
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient with corneal pathology, crystalline pathology, or pigmentary glaucoma
Patient with corneal pathology, crystalline pathology, or pigmentary glaucoma will be included.
Imaging by retroillumination will be realized. In case of bilateral disease, both eyes will be photographed
Retro-illuminator
The device Retro-illuminator will be used to photograph the eyes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Retro-illuminator
The device Retro-illuminator will be used to photograph the eyes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient having received an instillation of eye drops to dilate the pupil of the eye to be photographed (or of both eyes).
Exclusion Criteria
* Poor or no pupillary dilation: patient with allergy or intolerance to eye drops used for pupillary dilation, refusal of pupillary dilation
* Pregnant or breastfeeding patient
* Person under legal protection
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gilles THURET, MD PhD
Role: PRINCIPAL_INVESTIGATOR
CHU SAINT-ETIENNE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Saint-Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A01496-35
Identifier Type: OTHER
Identifier Source: secondary_id
21CH117
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.